MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-04-0048151
Byennet Pharmaceutical Private Limited
Byennet Pharmaceutical Private Limited - pharma in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹38.62 Lakh
▲ 19.42% YoY
Net profit · FY 2025
₹2.07 Lakh
Net margin 5.4%
EBITDA · FY 2025
₹3.65 Lakh
EBITDA margin 9.4%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹59.2 Lakh
Issued & subscribed
Open charges
₹15 Lakh
Satisfied ₹19.24 Lakh
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
About Byennet Pharmaceutical Private Limited
Data last updated:
Byennet Pharmaceutical Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017PTC293416. Its GSTIN is 27AAHCB1706G1ZZ (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹59.2 Lakh. It is led by directors Manjushri Sangle and Balaji Tukaram Sangle.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. B – 11 Yashwant Sankul – B Gajanan Maharaj Mandir Road, Aurangabad, Maharashtra, India – 431005.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.62 Lakh. For the same year it recorded a net profit of ₹2.07 Lakh (net margin 5.4%) and EBITDA of ₹3.65 Lakh (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over five years.
As per MCA filings, the company has open charges of ₹15 Lakh and satisfied charges of ₹19.24 Lakh on record.
Byennet Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0048151). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909MH2017PTC293416
Registration Number 293416
Incorporation Date 05 April 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-04-0048151
Recognitions & Rankings of Byennet Pharmaceutical
Contact details
Byennet Pharmaceutical Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. B – 11 Yashwant Sankul – B Gajanan Maharaj Mandir Road, Aurangabad, Maharashtra, India – 431005
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Byennet Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Byennet Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Byennet Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Byennet Pharmaceutical Private Limited, buy the company report.
Financials of Byennet Pharmaceutical Private Limited
FY 2025 filings availableByennet Pharmaceutical Private Limited reported revenue of ₹38.62 Lakh for FY 2025.
Revenue · FY 2025
₹38.62 Lakh
Net profit · FY 2025
₹2.07 Lakh margin 5.4%
EBITDA · FY 2025
₹3.65 Lakh margin 9.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 45%
3 years · compounded
▲ 3%
5 years · compounded
▲ 11%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.07 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.4% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Byennet Pharmaceutical Private Limited, buy the company report.
Board of directors of Byennet Pharmaceutical Private Limited
Byennet Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balaji Tukaram Sangle | Additional Director | 15 May 2017 | 9 Years 5 Months | Current |
| Manjushri Sangle | Director | 05 Apr 2017 | 9 Years 6 Months | Current |
Auditor
Byennet Pharmaceutical Private Limited is audited by JOSHI KULKARNI & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JOSHI KULKARNI & ASSOCIATES | FY 2020 | 122374W |
Shareholding
The shareholding of Byennet Pharmaceutical Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Byennet Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15 Lakh
Satisfied charges
₹19.24 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Sep 2023 | 100793365 | Others | ₹15 Lakh | Open | |
| 26 Aug 2019 | 100293074 | State Bank of India | ₹19.24 Lakh | Satisfied |
To see the full charge records of Byennet Pharmaceutical Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Byennet Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Byennet Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Byennet Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCB1706G1ZZ | Maharashtra | Active | 22 Sep 2017 |
To see the full GST registrations and return filing status of Byennet Pharmaceutical Private Limited, buy the company report.
Recent activity
Byennet Pharmaceutical Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Ashwini Jaybhaye Janu ceased to be Director on 17 Jul 2020.
AGM
Byennet Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Byennet Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 0.15 Cr with Charge ID 100793365 was registered on 05 Sep 2023.
Charges
A charge registered on 26 Aug 2019 via Charge ID 100293074 with State Bank Of India was fully satisfied on 15 Mar 2023.
Charges
A charge with State Bank Of India of Rs. 0.19 Cr registered on 26 Aug 2019 with Charge ID 100293074 was modified on 27 Jul 2020.
Ceased
Ashwini Jaybhaye Janu ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 0.19 Cr with Charge ID 100293074 was registered on 26 Aug 2019.
Ceased
Asmita Aghav Amar ceased to be Director.
Appointed
Balaji Tukaram Sangle was appointed as Additional Director.
Appointed
Manjushri Sangle was appointed as Director.
Incorporation
05 Apr 2017
Byennet Pharmaceutical Private Limited was registered on 05 Apr 2017 with Roc Mumbai Ii & aged 9 years 6 months as per MCA records.
Frequently asked questions
Byennet Pharmaceutical is an active private limited company based in Aurangabad, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 April 2017 (9+ years old) and is registered under CIN U51909MH2017PTC293416.
Byennet Pharmaceutical has 2 current directors:
- Balaji Tukaram Sangle - Additional Director
- Manjushri Sangle - Director
The latest financial statements of Byennet Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Byennet Pharmaceutical is 27AAHCB1706G1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Byennet Pharmaceutical is U51909MH2017PTC293416. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Byennet Pharmaceutical was incorporated on 05 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Ashwini Jaybhaye Janu ceased to be Director on 17 Jul 2020. Asmita Aghav Amar ceased to be Director on 01 Feb 2019. Balaji Tukaram Sangle was appointed as Additional Director on 15 May 2017. Byennet Pharmaceutical has 4 board changes on record in total.
Yes, Byennet Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-04-0048151).
The registered office of Byennet Pharmaceutical is at Flat No. B – 11 Yashwant Sankul – B Gajanan Maharaj Mandir Road, Aurangabad, Maharashtra, India – 431005.
Byennet Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.